After completing her bachelor’s degree (BSc Hons) in Neuroscience from the University of Nottingham (UK), Dr. Sara Abdulla joined the University of Cambridge (UK), where she was awarded a PhD in Clinical Neurosciences. While at Cambridge, she focused mainly on neurodegeneration and demyelination (Multiple Sclerosis). Her investigations delved into a deeper understanding of oligodendrocyte precursor cell (OPC) differentiation and transcriptional regulation in primary rat cultures, in vivo studies, OPC metabolism, neuronal precursor cell plasticity and spinal cord injury. Ultimately her goal was to identify potential targets that could lead to therapeutic avenues such as cell-based therapies or drug development.
Dr. Abdulla is passionate about neuroscience as she believes it is a field that is essential and growing. Her aim is to lead Qatar into a research-based society, becoming a part of the-on going discoveries in the field, and focusing on neuroscience related diseases and disorders that are prevalent to the region. Her current research aims at identifying biomarkers in Autism Spectrum Disorder, a multifactoral, neurodevelopmental disorder, that is of major concern in Qatar and the GCC. Furthermore, she hopes to further stem cell research in neuroscience in Qatar not only because of its important impact into understanding fundamental biological properties, but also for their remarkable potential on the study of disease and its prevention, clinical applications, and drug discovery and development.
Dr. Abdulla’s research interest mainly focuses on a deeper understanding of the mechanisms behind prenatal influences on neurodevelopment leading to Autism Spectrum Disorder.
Scientific Project Coordinator of QBRI’s Interdisciplinary Research Program
Project title: Identifying Potential Molecular Biomarkers for Autism Spectrum Disorder